These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mycobacterium tuberculosis pantothenate kinase: possible changes in location of ligands during enzyme action. Chetnani B, Das S, Kumar P, Surolia A, Vijayan M. Acta Crystallogr D Biol Crystallogr; 2009 Apr; 65(Pt 4):312-25. PubMed ID: 19307712 [Abstract] [Full Text] [Related]
4. Location and conformation of pantothenate and its derivatives in Mycobacterium tuberculosis pantothenate kinase: insights into enzyme action. Chetnani B, Kumar P, Abhinav KV, Chhibber M, Surolia A, Vijayan M. Acta Crystallogr D Biol Crystallogr; 2011 Sep; 67(Pt 9):774-83. PubMed ID: 21904030 [Abstract] [Full Text] [Related]
5. Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosis. Awasthy D, Ambady A, Bhat J, Sheikh G, Ravishankar S, Subbulakshmi V, Mukherjee K, Sambandamurthy V, Sharma U. Microbiology (Reading); 2010 Sep; 156(Pt 9):2691-2701. PubMed ID: 20576686 [Abstract] [Full Text] [Related]
9. Invariance and variability in bacterial PanK: a study based on the crystal structure of Mycobacterium tuberculosis PanK. Das S, Kumar P, Bhor V, Surolia A, Vijayan M. Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):628-38. PubMed ID: 16699190 [Abstract] [Full Text] [Related]
12. The structure of the pantothenate kinase.ADP.pantothenate ternary complex reveals the relationship between the binding sites for substrate, allosteric regulator, and antimetabolites. Ivey RA, Zhang YM, Virga KG, Hevener K, Lee RE, Rock CO, Jackowski S, Park HW. J Biol Chem; 2004 Aug 20; 279(34):35622-9. PubMed ID: 15136582 [Abstract] [Full Text] [Related]
13. Biochemical and structural studies of mutants indicate concerted movement of the dimer interface and ligand-binding region of Mycobacterium tuberculosis pantothenate kinase. Paul A, Kumar P, Surolia A, Vijayan M. Acta Crystallogr F Struct Biol Commun; 2017 Nov 01; 73(Pt 11):635-643. PubMed ID: 29095158 [Abstract] [Full Text] [Related]
17. Assessment of Mycobacterium tuberculosis pantothenate kinase vulnerability through target knockdown and mechanistically diverse inhibitors. Reddy BK, Landge S, Ravishankar S, Patil V, Shinde V, Tantry S, Kale M, Raichurkar A, Menasinakai S, Mudugal NV, Ambady A, Ghosh A, Tunduguru R, Kaur P, Singh R, Kumar N, Bharath S, Sundaram A, Bhat J, Sambandamurthy VK, Björkelid C, Jones TA, Das K, Bandodkar B, Malolanarasimhan K, Mukherjee K, Ramachandran V. Antimicrob Agents Chemother; 2014 Jun 01; 58(6):3312-26. PubMed ID: 24687493 [Abstract] [Full Text] [Related]
18. Kinetics and regulation of pantothenate kinase from Escherichia coli. Song WJ, Jackowski S. J Biol Chem; 1994 Oct 28; 269(43):27051-8. PubMed ID: 7929447 [Abstract] [Full Text] [Related]
19. The crystal structure of a novel phosphopantothenate synthetase from the hyperthermophilic archaea, Thermococcus onnurineus NA1. Kim MK, An YJ, Cha SS. Biochem Biophys Res Commun; 2013 Oct 04; 439(4):533-8. PubMed ID: 24021277 [Abstract] [Full Text] [Related]
20. Inhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections. Choudhry AE, Mandichak TL, Broskey JP, Egolf RW, Kinsland C, Begley TP, Seefeld MA, Ku TW, Brown JR, Zalacain M, Ratnam K. Antimicrob Agents Chemother; 2003 Jun 04; 47(6):2051-5. PubMed ID: 12760898 [Abstract] [Full Text] [Related] Page: [Next] [New Search]